uniQure NV
QURE
19.35
-0.88
-4.35%
uniQure NV
US · QURE
#2954 by market cap
Listed 1970
19.35
-0.88
-4.35%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About uniQure NV
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
- Founded
- 1998
- CEO
- Mr. Matthew C. Kapusta
- Employees
- 221
- Headquarters
- Amsterdam, Noord-Holland, Netherlands (the)
- Fiscal year end
- 12-31
- Website
- uniqure.com
Company profile
- Exchange
- US
- Symbol
- QURE
- Market-cap rank
- #2954
- Listing date
- 1970-01-01
- Market cap
- 1.36B
- Float cap
- 1.13B
- Shares out
- 70.14M
- Float shares
- 58.29M
Sectors & themes
Biotechnology
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
uniQure NV discussion 0 comments